Showing results (1-10 of 169) with videos related to

Sort By:
Pageof 17
Nature Reviews. Drug Discovery|September 6, 2014
Strategies to improve drug development for sepsisMitchell P Fink, H Shaw Warren
The Journal of Infectious Diseases|November 1, 2003
Protective efficacy of CAP18106-138-immunoglobulin G in sepsisH Shaw Warren, Robina Matyal, Jennifer E Allaire, et al.
Novartis Foundation Symposium|March 27, 2007
Ethyl pyruvate: a novel treatment for sepsisMitchell P Fink
Critical Care Clinics|March 26, 2002
Cytopathic hypoxia. Is oxygen use impaired in sepsis as a result of an acquired intrinsic derangement in cellular respiration?Mitchell P Fink
Kidney International|October 2, 2008
Animal models of sepsis and its complicationsMitchell P Fink
Critical Care (London, England)|July 17, 2014
HMGB1 as a drug target in staphylococcal pneumoniaMitchell P Fink
Current Opinion in Clinical Nutrition and Metabolic Care|February 15, 2002
Reactive oxygen species as mediators of organ dysfunction caused by sepsis, acute respiratory distress syndrome, or hemorrhagic shock: potential benefits of resuscitation with Ringer's ethyl pyruvate solutionMitchell P Fink
Critical Care (London, England)|December 21, 2002
Bench-to-bedside review: Cytopathic hypoxiaMitchell P Fink
Virulence|September 12, 2013
Animal models of sepsisMitchell P Fink
Current Opinion in Critical Care|March 27, 2003
Intestinal epithelial hyperpermeability: update on the pathogenesis of gut mucosal barrier dysfunction in critical illnessMitchell P Fink
Pageof 17